- Home
- Supplements
- Apigenin
- Neuroprotection
Apigenin for Neuroprotection
Neuroprotective effects are confined to cell and animal models.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- No human dose established
- Expected timeframe
- Not established
Protocol
- studied dose
- Preclinical ischaemia and neurodegeneration models only, at doses not translatable to human intake
- evidence note
- Verdict is insufficient - no human neurological outcome data exists
- what happened
- Reduced neuronal loss in animal paradigms; nothing has been measured in people
- better first choices
- Omega-3 fatty acids and blood pressure control have real human neurological outcome data
- if you still trial it
- Dietary sources such as parsley, celery and chamomile tea are the sensible route, with no reason to expect a neurological effect
Evidence
What the studies say
No studies are yet linked to both Apigenin and Neuroprotection.
Safety
Caveats
Extrapolating animal neuroprotection to humans has failed repeatedly for flavonoids. Apigenin inhibits CYP enzymes and may interact with medications. Low oral bioavailability. Avoid in pregnancy.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.